Metformin has been shown to be associated with a decreased death risk, improved clinical outcomes, and delayed progression to ESRD in patients with DKD ( in vitro and vivo have shown that metformin attenuates the progression of DKD by suppressing renal inflammation, oxidative stress, and fibrosis ( in vitro upon high glucose exposure ( In conclusion, metformin could ameliorate inflammation and oxidative stress in renal tubular cells, regulate apoptosis and autophagy, and attenuate tubulointerstitial damage through various mechanisms
However, certain genetic profiles may correlate with higher micronutrient demands, suggesting that MIC B12 or supplementation could support better peptide outcomes when interpreted with a qualified healthcare provider
The refined flour adds empty calories with minimal nutritional value
Digestive adaptation over time As the body adjusts to treatment, digestive function usually stabilises
Have a safer and more effective health journey